Frontlight ResearchEarly access
Trial site
The Sarah Cannon Research Institute.
- 1running trial
- 5closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Lung cancer2 trials
- Triple-negative breast cancer2 trials
- Endometrial cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 23 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 31 trial
- Status
- Completed4 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Pfizer4 trials
- Inspirna, Inc.1 trial
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Closed trials
Completed
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer
Terminated
Completed
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026